Experiment Catalog

Experiments are listed here in reverse chronological order. Currently, each corresponds to a Heat Diffusion Experiment, but other experiment types will be added in the future (e.g., Reverse Causal Reasoning).

Additional analyses can be run directly on a network through the network catalog or by first building a query and clicking the analyze button in the biological network explorer. Also, see the Omics Catalog of publicly uploaded -omics data sets.

Created N Query Omic Name Omic Description
49 2018-06-13 12:32:47 100 1044 GSE63063_GPL6947_AD Patients from GSE63063 with mild cognitive impairment (batch 1/GPL10558)
50 2018-06-13 12:32:47 100 1044 GSE63063_GPL6947_MCI Patients from GSE63063 with Alzheimer's disease (batch 1/GPL10558)
51 2018-06-13 12:32:47 100 1044 GSE63063_GPL10558_AD Patients from GSE63063 with mild cognitive impairment (batch 2/GPL10558)
52 2018-06-13 12:32:47 100 1044 GSE63063_GPL10558_MCI Patients from GSE63063 with Alzheimer's disease (batch 2/GPL10558)
46 2018-06-13 12:32:40 100 1044 GSE28146_incipient Patients from GSE28146 with incipient Alzheimer's disease
47 2018-06-13 12:32:40 100 1044 GSE28146_moderate Patients from GSE28146 with moderate Alzheimer's disease
48 2018-06-13 12:32:40 100 1044 GSE28146_severe Patients from GSE28146 with severe Alzheimer's disease
43 2018-06-13 12:32:34 100 1044 GSE1297_incipient Patients from GSE1297 with incipient Alzheimer's disease
44 2018-06-13 12:32:34 100 1044 GSE1297_moderate Patients from GSE1297 with moderate Alzheimer's disease
45 2018-06-13 12:32:34 100 1044 GSE1297_severe Patients from GSE1297 with severe Alzheimer's disease
39 2018-04-03 17:03:21 250 32 GSE63063_GPL6947_AD Patients from GSE63063 with mild cognitive impairment (batch 1/GPL10558)
40 2018-04-03 17:03:21 250 32 GSE63063_GPL6947_MCI Patients from GSE63063 with Alzheimer's disease (batch 1/GPL10558)
41 2018-04-03 17:03:21 250 32 GSE63063_GPL10558_AD Patients from GSE63063 with mild cognitive impairment (batch 2/GPL10558)
42 2018-04-03 17:03:21 250 32 GSE63063_GPL10558_MCI Patients from GSE63063 with Alzheimer's disease (batch 2/GPL10558)
36 2018-04-03 17:03:11 250 32 GSE28146_incipient Patients from GSE28146 with incipient Alzheimer's disease
37 2018-04-03 17:03:11 250 32 GSE28146_moderate Patients from GSE28146 with moderate Alzheimer's disease
38 2018-04-03 17:03:11 250 32 GSE28146_severe Patients from GSE28146 with severe Alzheimer's disease
33 2018-04-03 17:03:00 250 32 GSE1297_incipient Patients from GSE1297 with incipient Alzheimer's disease
34 2018-04-03 17:03:00 250 32 GSE1297_moderate Patients from GSE1297 with moderate Alzheimer's disease
35 2018-04-03 17:03:00 250 32 GSE1297_severe Patients from GSE1297 with severe Alzheimer's disease
29 2018-04-03 16:57:11 250 31 GSE63063_GPL6947_AD Patients from GSE63063 with mild cognitive impairment (batch 1/GPL10558)
30 2018-04-03 16:57:11 250 31 GSE63063_GPL6947_MCI Patients from GSE63063 with Alzheimer's disease (batch 1/GPL10558)
31 2018-04-03 16:57:11 250 31 GSE63063_GPL10558_AD Patients from GSE63063 with mild cognitive impairment (batch 2/GPL10558)
32 2018-04-03 16:57:11 250 31 GSE63063_GPL10558_MCI Patients from GSE63063 with Alzheimer's disease (batch 2/GPL10558)
26 2018-04-03 16:57:01 250 31 GSE28146_incipient Patients from GSE28146 with incipient Alzheimer's disease
27 2018-04-03 16:57:01 250 31 GSE28146_moderate Patients from GSE28146 with moderate Alzheimer's disease
28 2018-04-03 16:57:01 250 31 GSE28146_severe Patients from GSE28146 with severe Alzheimer's disease
23 2018-04-03 16:56:51 250 31 GSE1297_incipient Patients from GSE1297 with incipient Alzheimer's disease
24 2018-04-03 16:56:51 250 31 GSE1297_moderate Patients from GSE1297 with moderate Alzheimer's disease
25 2018-04-03 16:56:51 250 31 GSE1297_severe Patients from GSE1297 with severe Alzheimer's disease
19 2018-04-03 16:56:41 25 30 GSE63063_GPL6947_AD Patients from GSE63063 with mild cognitive impairment (batch 1/GPL10558)
20 2018-04-03 16:56:41 25 30 GSE63063_GPL6947_MCI Patients from GSE63063 with Alzheimer's disease (batch 1/GPL10558)
21 2018-04-03 16:56:41 25 30 GSE63063_GPL10558_AD Patients from GSE63063 with mild cognitive impairment (batch 2/GPL10558)
22 2018-04-03 16:56:41 25 30 GSE63063_GPL10558_MCI Patients from GSE63063 with Alzheimer's disease (batch 2/GPL10558)
16 2018-04-03 16:56:39 25 30 GSE28146_incipient Patients from GSE28146 with incipient Alzheimer's disease
17 2018-04-03 16:56:39 25 30 GSE28146_moderate Patients from GSE28146 with moderate Alzheimer's disease
18 2018-04-03 16:56:39 25 30 GSE28146_severe Patients from GSE28146 with severe Alzheimer's disease
13 2018-04-03 16:56:38 25 30 GSE1297_incipient Patients from GSE1297 with incipient Alzheimer's disease
14 2018-04-03 16:56:38 25 30 GSE1297_moderate Patients from GSE1297 with moderate Alzheimer's disease
15 2018-04-03 16:56:38 25 30 GSE1297_severe Patients from GSE1297 with severe Alzheimer's disease
12 2018-04-03 16:27:06 100 29 ModerateAD Moderate AD
11 2018-04-03 16:26:53 100 29 SevereAD Severe AD
7 2018-04-03 15:20:49 25 22 GSE63063_GPL6947_AD Patients from GSE63063 with mild cognitive impairment (batch 1/GPL10558)
8 2018-04-03 15:20:49 25 22 GSE63063_GPL6947_MCI Patients from GSE63063 with Alzheimer's disease (batch 1/GPL10558)
9 2018-04-03 15:20:49 25 22 GSE63063_GPL10558_AD Patients from GSE63063 with mild cognitive impairment (batch 2/GPL10558)
10 2018-04-03 15:20:49 25 22 GSE63063_GPL10558_MCI Patients from GSE63063 with Alzheimer's disease (batch 2/GPL10558)
4 2018-04-03 15:20:48 25 22 GSE28146_incipient Patients from GSE28146 with incipient Alzheimer's disease
5 2018-04-03 15:20:48 25 22 GSE28146_moderate Patients from GSE28146 with moderate Alzheimer's disease
6 2018-04-03 15:20:48 25 22 GSE28146_severe Patients from GSE28146 with severe Alzheimer's disease
1 2018-04-03 15:20:46 25 22 GSE1297_incipient Patients from GSE1297 with incipient Alzheimer's disease
2 2018-04-03 15:20:46 25 22 GSE1297_moderate Patients from GSE1297 with moderate Alzheimer's disease
3 2018-04-03 15:20:46 25 22 GSE1297_severe Patients from GSE1297 with severe Alzheimer's disease

About

BEL Commons is developed and maintained in an academic capacity by Charles Tapley Hoyt and Daniel Domingo-Fernández at the Fraunhofer SCAI Department of Bioinformatics with support from the IMI project, AETIONOMY. It is built on top of the open source project, PyBEL. Please feel free to contact us here to give us feedback or report any issues.